PCM
INBX icon

Presidio Capital Management’s Inhibrx INBX Stock Holding History

Presidio Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Hold
3,394
– – 0.08% 59
2026
Q1 		$228K Hold
3,394
– – 0.07% 61
2025
Q4 		$268K Buy
+3,394
New +$231K 0.08% 59

Other funds holding INBX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CGIM
Cannon Global Investment Management Davie, Florida $35.4M AUM 47.4% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Presidio Capital Management's INBX Position: Q2 2026 in Review

Presidio Capital Management held its Inhibrx (INBX) position steady in Q2 2026 at 3,394 shares worth $322K. The position accounts for 0.08% of the portfolio, ranked #59.

Presidio Capital Management first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. 23 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Presidio Capital Management held 3,394 shares of Inhibrx worth $322K as of Q2 2026.
  • Presidio Capital Management left its Inhibrx share count unchanged in Q2 2026.
  • Inhibrx made up 0.08% of Presidio Capital Management's portfolio in Q2 2026, its #59 holding.
  • Presidio Capital Management first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
  • 23 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Presidio Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.